B+
Bull case
20%
Probability
Target price
$37.91
Analysis reference price unavailable
Analysis 2025-11-17 · RankAlpha Sentiment AI
ORKA
Oruka TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive clinical readout, a partnering deal, or early commercial traction could re-rate the stock significantly above the close; upside is concentrated in near-term data/partnering events.
Posture
Defensive
Lead driver
Value
What changed
2 setup hits (3d) with net bullish as of 2026-10-27.
What can break
Clinical failure, a short cash runway forcing dilutive financing, or regulatory delays would likely produce material downside toward the bear target.
Momentum
54
Value
41
Sentiment
0
Setup hits (3d)
2 · Net Bullish
AI TargetsBase $27.08 · Bull $37.91 · Bear $16.25Analysis 2025-11-17; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-27 • Model: HYBRID_IC_RP
AI Memo
As of 2025-11-17 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-10-27
Investment thesis
As of 2026-10-27
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-27. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Bullish
Target $152.23
Why
Momentum54 · Δ7d +33.4
Value41 · Δ7d -0.1
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Confirming evidence
- • 2 setup hits (3d) with net bullish as of 2026-10-27.
- • Value remains the lead driver in the composite, 7D delta -0.1.
Contradictions & invalidation
- • Clinical failure, a short cash runway forcing dilutive financing, or regulatory delays would likely produce material downside toward the bear target.
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
No dated catalyst is available.
Lead driver: Value · See fundamentals
Momentum
54
8% active weight
Current posture
7d trendImproving
Δ7d
+33.4
Δ21d
-15.5
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.3
Sentiment
0
45% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade F. Momentum 54.2 / Value 40.6 / Sentiment 0.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-11-17. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$27.08
Analysis reference price unavailable
Analysis 2025-11-17 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$16.25
Analysis reference price unavailable
Analysis 2025-11-17 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$6.34B
Beta
-0.37
Shares Out
66.21M
P/E (TTM) · Derived
-41.5
P/S (TTM)
-
P/FCF (TTM) · Derived
-51.38
Rev YoY
-100.0%
EPS YoY
+12.3%
Gross Margin
-
Op Margin
-
Net Debt
-$335.11M
Current Ratio
38.51
As of 2026-10-27 • Updated nightlySource: Internal modelMethods & Data